Nurse-led medicines' monitoring in care homes, implementing the Adverse Drug Reaction (ADRe) Profile improvement initiative for mental health medicines: An observational and interview study.
Susan JordanTimothy BannerMarie Gabe-WaltersJane M MikhailGerwyn PanesJeff RoundSherrill SnelgroveMel StoreyDavid Hughesnull nullPublished in: PloS one (2019)
To our knowledge, ADRe is the only instrument that brings a full account of patients' problems to medication reviews. This juxtaposition of signs and symptoms against prescriptions facilitates dose adjustments and de-prescribing and leads to: reduced pain and sedation; early identification of problems linked to ADRs, such as falls; and timely medication reviews e.g. for dyspnoea.
Keyphrases
- adverse drug
- mental health
- healthcare
- quality improvement
- end stage renal disease
- primary care
- electronic health record
- emergency department
- ejection fraction
- chronic kidney disease
- chronic pain
- pain management
- newly diagnosed
- palliative care
- patient reported outcomes
- drug induced
- prognostic factors
- systematic review
- spinal cord injury
- intensive care unit
- physical activity
- depressive symptoms
- community dwelling
- acute respiratory distress syndrome
- health insurance